scholarly journals Clinical Usefulness of Serum Autotaxin for Early Prediction of Relapse in Male Patients with Type 1 Autoimmune Pancreatitis

2020 ◽  
Author(s):  
Ayami Fukiage ◽  
Hatsue Fujino ◽  
Daiki Miki ◽  
Yasutaka Ishii ◽  
Masahiro Serikawa ◽  
...  
Keyword(s):  
Autoimmune Pancreatitis ◽  
Clinical Usefulness ◽  
Early Prediction ◽  
Type 1 Autoimmune Pancreatitis ◽  
Male Patients ◽  
Prediction Of Relapse

Serum and histological IgG4-negative type 1 autoimmune pancreatitis

2018 ◽  
Vol 12 (3) ◽  
pp. 232-238 ◽  
Author(s):  
Yuichi Takano ◽  
Takahiro Kobayashi ◽  
Fumitaka Niiya ◽  
Eiichi Yamamura ◽  
Naotaka Maruoka ◽  
...  
Keyword(s):  
Autoimmune Pancreatitis ◽  
Negative Type ◽  
Type 1 Autoimmune Pancreatitis

scholarly journals Type 1 autoimmune pancreatitis

2011 ◽  
Vol 6 (1) ◽  
pp. 82 ◽  
Author(s):  
Yoh Zen ◽  
Dimitrios P Bogdanos ◽  
Shigeyuki Kawa
Keyword(s):  
Autoimmune Pancreatitis ◽  
Type 1 Autoimmune Pancreatitis

Clinical Evaluation of International Consensus Diagnostic Criteria for Type 1 Autoimmune Pancreatitis in Comparison With Japanese Diagnostic Criteria 2011

Pancreas ◽  
2013 ◽  
Vol 42 (8) ◽  
pp. 1238-1244 ◽  
Author(s):  
Itaru Naitoh ◽  
Takahiro Nakazawa ◽  
Kazuki Hayashi ◽  
Katsuyuki Miyabe ◽  
Shuya Shimizu ◽  
...  
Keyword(s):  
Diagnostic Criteria ◽  
Clinical Evaluation ◽  
Autoimmune Pancreatitis ◽  
International Consensus ◽  
Type 1 Autoimmune Pancreatitis

scholarly journals Extracellular vesicles microRNA analysis in type 1 autoimmune pancreatitis: Increased expression of microRNA-21

Pancreatology ◽  
2020 ◽  
Vol 20 (3) ◽  
pp. 318-324
Author(s):  
Koh Nakamaru ◽  
Takashi Tomiyama ◽  
Sanshiro Kobayashi ◽  
Manami Ikemune ◽  
Satoshi Tsukuda ◽  
...  
Keyword(s):  
Extracellular Vesicles ◽  
Autoimmune Pancreatitis ◽  
Type 1 Autoimmune Pancreatitis

Pancreaticobiliary involvement in treated type 1 autoimmune pancreatitis: Imaging pattern and risk factors for disease relapse

2019 ◽  
Vol 120 ◽  
pp. 108673 ◽  
Author(s):  
Liang Zhu ◽  
Hua-dan Xue ◽  
Wen Zhang ◽  
Qiang Wang ◽  
Bei Tan ◽  
...  
Keyword(s):  
Risk Factors ◽  
Autoimmune Pancreatitis ◽  
Disease Relapse ◽  
Type 1 Autoimmune Pancreatitis

A case of high‐grade pancreatic intraepithelial neoplasia concomitant with type 1 autoimmune pancreatitis: The process underlying both conditions

2019 ◽  
Vol 69 (3) ◽  
pp. 165-171
Author(s):  
Tomoko Sugiyama ◽  
Takuma Tajiri ◽  
Shinichiro Hiraiwa ◽  
Tomohisa Machida ◽  
Hiroyuki Ito ◽  
...  
Keyword(s):  
Autoimmune Pancreatitis ◽  
Intraepithelial Neoplasia ◽  
High Grade ◽  
Pancreatic Intraepithelial Neoplasia ◽  
Type 1 Autoimmune Pancreatitis

scholarly journals Kidney Involvement in Patients with Type 1 Autoimmune Pancreatitis

2019 ◽  
Vol 8 (2) ◽  
pp. 258
Author(s):  
Miroslav Vujasinovic ◽  
Raffaella Pozzi Mucelli ◽  
Roberto Valente ◽  
Caroline Verbeke ◽  
Stephan Haas ◽  
...  
Keyword(s):  
Autoimmune Pancreatitis ◽  
Lymphocytic Infiltration ◽  
Normal Serum ◽  
International Consensus ◽  
Kidney Involvement ◽  
Type 1 Autoimmune Pancreatitis ◽  
Elevated Creatinine ◽  
Imaging Signs

Introduction: Autoimmune pancreatitis (AIP) type 1 is a special form of chronic pancreatitis with a strong lymphocytic infiltration as the pathological hallmark and other organ involvement (OOI). IgG4-related kidney disease (IgG4-RKD) was first reported as an extrapancreatic manifestation of AIP in 2004. The aim of the present study was to determine the frequency and clinical impact of kidney lesions observed in patients with AIP type 1. Methods: We performed a single-centre retrospective study on a prospectively collected cohort of patients with a histologically proven or highly probable diagnosis of AIP according to the International Consensus Diagnostic Criteria (ICDC) classification. Results: Seventy-one patients with AIP were evaluated. AIP type 1 was diagnosed in 62 (87%) patients. Kidney involvement was present in 17 (27.4%) patients with AIP type 1: 15 (88.2%) males and 2 (11.8%) females. Laboratory and/or imaging signs of kidney involvement were presented at the time of AIP diagnosis in eight (47.1%) patients. In other patients, the onset of kidney involvement occurred between four months and eight years following diagnosis. At the time of the diagnosis of kidney involvement, eight (47.1%) patients showed elevated creatinine, and nine (52.9%) patients showed normal serum creatinine. None of the patients were treated with dialysis. Conclusions: IgG4-RKD was present in 27.4% of patients with AIP type 1, with male gender predominance. In cases of early diagnosis and cortisone treatment, the clinical course was mild in most cases. Regular laboratory control of renal function should be a part of the follow-up of patients with AIP type 1.

Sign in / Sign up

Export Citation Format

Share Document